Search Results for: 13485

Good Documentation Practices (GDP 101) Webinar

good documetnation practice GDP101 300x261 Good Documentation Practices (GDP 101) Webinar
No White Out!

Medical Device Academy released a new webinar this week for training companies on good documentation practices.

Have you ever wondered where the FDA regulation is that says, “…shall not use white-out to correct quality system records.”

Don’t bother looking, because you won’t find it. You also won’t find any regulations against the use of red pens, highlighters, pencils, or markers. You can’t even find a guidance document that tells you not to put a single line through mistakes, initial and date it.

The applicable regulation is 21 CFR 820.180, but the regulation doesn’t specifically say these things. Instead, the regulation states: “Records shall be legible and shall be stored to minimize deterioration and to prevent loss.” The ISO 13485 Standard is not much different. It states that you must establish a procedure that will “Define the controls needed for the identification, storage, protection, retrieval, retention time and disposition of records.”

Over time medical device companies have developed some standard approaches to meet the requirements for Document Control, Control of Records, and Training. These are the three core processes that I call “good documentation practices.” If you need training or you need tools for training employees, click on the link below to purchase our new webinar on good documentation practices.

http://robertpackard.wpengine.com/good-documentation-practices-webinar/

The webpage also includes an exam for training people on good documentation practices. The exam serves as a useful check for the training, but we recommend that process owners monitor these processes–especially if the process is manual. For example, QC inspectors will complete inspection records and file the record as a quality system record. The QC supervisor, or process owner, should periodically review these records for completeness and accuracy. If the supervisor notices an error, the supervisor should notify the inspector and have them correct the mistake. The supervisor should also track how many times each error is made and specifically where errors are occurring. The collection of this data gives the supervisor trend data to help them identify which forms need to be updated to prevent mistakes and which employees require retraining. This data also provides evidence of competency for each employee concerning good documentation practices.

After you have completed the training, you might also be interested in downloading our procedures for Document Control, Control of Records and Training:

http://robertpackard.wpengine.com/standard-operating-procedures-medical-device-academy/

Good Documentation Practices (GDP 101) Webinar Read More »

Good Documentation Practices “GDP 101” Webinar

This webinar, presented by subject matter expert, Rob Packard of Medical Device Academy, provides training on good documentation practices (GDPs) for compliance with both ISO 13485 and 21 CFR 820. Good documentation practices consists of: 1) Document Control, 2) Control of Records, and 3) Training.

Applicable Regulations & Clauses for Good Documentation Practices

The applicable regulation for document control is 21 CFR 820.40 and ISO 13485:2016, Clause 4.2.4 (yes, numbering changed in the 2016 version). The applicable regulations for control of records are 21 CFR 820.180 and 21 CFR Part 11. Sub-section 180 is the medical device specific portion of the regulations, but Part 11 covers the requirements for electronic records. Both parts are addressed in the is training. The applicable clause in the standard is ISO 13485:2016, Clause 4.2.5. Finally, training is included with this presentation, because most companies that are implementing procedures for control of documents and records also need training records and documented training requirements for all of their employees.

Topics for “Good Documentation Practices 101” include:

Your cart is empty

good documetnation practice GDP101 Good Documentation Practices GDP 101 Webinar

This webinar recording is only $129 (AND INCLUDES NATIVE SLIDE POWERPOINT PRESENTATION FILES):

good documetnation practice GDP101 300x2612 150x150 Good Documentation Practices GDP 101 Webinar
Good Documentation Practices "GDP 101" Webinar
This webinar, presented by subject matter expert, Rob Packard of Medical Device Academy, provides detail related to Good Documentation Practice (GDP) compliance requirements for both ISO 13485 and 21 CFR 820.
Price: $129.00

10- Question Exam and Training Certificate available for $49.00:

exam gdp101 Good Documentation Practices GDP 101 Webinar
Good Documentation Practices Exam
This is a 10 question quiz with multiple choice and fill in the blank questions. The completed quiz is to be submitted by email to Rob Packard as an MS Word document. Rob will provide a corrected exam with explanations for incorrect answers and a training effectiveness certificate for grades of 70% or higher.
Price: $49.00

VIEW OUR PROCEDURES – CLICK HERE OR IMAGE BELOW:

SOPS Good Documentation Practices GDP 101 Webinar

About Your Instructor

Rob Packard Headshot from 2015 10x 300x246 Good Documentation Practices GDP 101 WebinarRob Packard is a regulatory consultant with 20 years experience in the medical device, pharmaceutical and biotechnology industries. He is a graduate of UConn in Chemical Engineering. Robert was a senior manager at several medical device companies—including President/CEO of a laparoscopic imaging company. His Quality Management System expertise covers all aspects of developing, training, implementing, and maintaining ISO 13485 and ISO 14971 certification. From 2009-2012, he was a lead auditor and instructor for one of the largest Notified Bodies. Robert’s specialty is regulatory submissions for high-risk medical devices, such as implants and drug/device combination products for CE marking applications, Canadian medical device applications and 510(k) submissions. The most favorite part of his job is training others. Specialties: CE Marking, Canadian Medical Device Applications, Post-Marketing Activities, Supplier Quality, CAPA, Risk Management, Auditing, Sterilization Validation, Lean Manufacturing, Silicone Chemistry, Extrusion, Bioprocess Engineering, and Strategy. He can be reached via phone 802.258.1881 or email. You can also follow him on Google+, LinkedIn or Twitter.

Good Documentation Practices “GDP 101” Webinar Read More »

Auditing the Nonconforming Material Process-21 CFR 820.90-Part III

This blog, “Auditing the Nonconforming Material Process-21 CFR 820.90,” identifies process interactions with the nonconforming material process. 

auditing for compliance 21CFR 829.90 Auditing the Nonconforming Material Process 21 CFR 820.90 Part III

Nonconforming material is not a “bad” thing in and of itself. Having no nonconformities is conspicuous. There are three critical aspects to verify when you are auditing nonconforming materials:

  1. nonconforming materials are identified and segregated
  2. disposition of nonconforming materials is appropriate
  3. feedback from the nonconforming material process interacts with other processes

This article focuses on the third aspect–process interactions. The most efficient method for auditing process interactions is to use turtle diagrams because turtle diagrams provide a systematic framework for identifying process linkages (http://bit.ly/Process-Approach).

Turtle Diagram Step 1

The first step of completing a turtle diagram involves identifying the process owner and obtaining a brief description of the process. This typically will not lead directly to the identification of process interactions–unless the person being interviewed describes the process using a process flow diagram.

Turtle Diagram Step 2

The second step of completing a turtle diagram is where the auditor identifies inputs of raw materials and information to the process. For nonconforming materials, the key is to review the incoming inspection record and the trend of nonconformities from the supplier. In a thorough investigation of the root cause for nonconforming raw materials, an investigator may recalculate the process capability for each dimension to determine if the process capability has shifted since the original process validation by the supplier.

Turtle Diagram Step 3

In the third step of completing a turtle diagram, the auditor documents the flow of product and information when the process is done. The transfer from one process to another will often involve an in-process inspection and updating of the product status. The best practice is to identify these in-process inspection steps in a risk control plan as part of the overall process risk controls for product realization. Although risk control plans are not required in most companies, they will become more prevalent as companies update their quality systems to a risk-based process for compliance with the 2015 version of ISO 9001.

Turtle Diagram Step 4

The fourth step of the turtle diagram identifies calibration, maintenance, and validation that applies to the process of being audited. It is common for nonconformities to occur when measurement devices are out-of-calibration, or equipment is not adequately maintained. Therefore, auditors should always ask what device was used to measure a nonconformity, and what equipment was used to manufacture the product. Auditors should also review calibration and maintenance records for evidence that corrections are being made frequently.

Whenever frequent corrections are needed, the probability of devices being out-of-calibration and/or equipment malfunctioning increases. Auditors should also verify that the process parameters in use match the validated process parameters. Ideally, validation of process parameters is also directly linked to process risk analysis, and in-process inspections are performed whenever process capability is inadequate to ensure conforming parts. If an auditor observes a high frequency of nonconformities, then an in-process inspection should be implemented for containment, and the validation report should be compared to current process performance.

Turtle Diagram Step 5

The fifth step of completing a turtle diagram involves the identification of personnel and sampling training records. The procedure for control of nonconforming material should be required training for anyone responsible for initiating, investigating, or completing a nonconforming product record (i.e., NCR). Critical interactions to verify for effectiveness are related to process changes. If a procedure changes, training may need to be updated. An auditor should verify that there is a mechanism for tracking which revision of the procedure each person is trained to. In addition, training records should verify that training requirements are documented, training is effective, and that the person can demonstrate competency by correctly completing the sections of an NCR form. The auditor can review completed records to verify competency, but the auditor can also interview personnel and ask hypothetical questions.

Turtle Diagram Step 6

The sixth step of completing a turtle diagram involves the identification of all applicable controlled documents, such as procedures, work instructions, and forms. The auditor should also verify that the process for control of external standards is effective. In the case of controlling nonconforming product, there are seldom any applicable external standards. However, it is critical to verify that the current forms and NCR identification methods are being used for control of nonconforming product.

Turtle Diagram Step 7

The seventh and final step of the turtle diagram is data analysis of metrics and quality objectives for a process. For control of nonconforming product, there should be evidence of statistical analysis of the nonconforming product to identify the need for corrective actions. This is a requirement of 21 CFR 820.250. This data analysis should then be used to quantify process risks that may be used for decision-making and to explain those decisions during regulatory audits.

The above process interactions are just examples, and auditors may identify other essential process interactions during an audit. Each process interaction that touches a record of nonconforming product is a potential audit trail that could lead to value-added findings to prevent future nonconformities.

If you need help improving your process for controlling nonconforming product, or with auditing in general, please email Rob Packard.

Auditing the Nonconforming Material Process-21 CFR 820.90-Part III Read More »

CE Marking Procedure (SYS-025)

This CE Marking procedure defines the requirements for technical documentation to comply with the new EU MDR (i.e. Regulation 2017/745).

Your cart is empty
CE Marking CE Marking Procedure (SYS 025)

When this procedure was first created in 2012, it was specific to technical documentation requirements for the MDD (93/42/EEC as modified by 2007/47/EC). As of May 26, 2021, MedTech companies will need to comply with Regulation (EU) 2017/745 (the new EU MDR), and this procedure has been completely rewritten to comply with the new EU regulations. This procedure also meets the requirements for ISO 13485:2016, Clauses 4.1. and the following is a list of documents included:

  • SYS-025 A, Technical Documentation Procedure
  • FRM-049 A, General Safety and Performance Requirements (GSPR) Checklist
  • FRM-039 A, Declaration of Conformity Template
  • FRM-040 A, Technical File Index/Device Master Record Index Template

CE Marking CE Marking Procedure (SYS 025)
SYS-025 CE Marking Procedure/Forms
SYS-025 CE Marking Procedure / Forms
Price: $299.00

The CE Marking procedure listed above is compliant with the new MDR (Regulation 2017/745). The Declaration of Conformity Template and the GSPR Checklist have both been updated to the new regulations.  The new regulations for CE Marking of medical devices become effective on May 26, 2021. Until then, the MDD requirements will be applicable. If you need the previous versions of our CE Marking procedure and forms, please let us know.

Anyone who purchased an older version of this procedure from us is entitled to an updated version of the procedure and forms at no additional cost.

If your firm is preparing for compliance with the new MDR, you might also be interested in the following information provided on this website:

Please note: This product will be delivered to the email address provided in the shopping cart transaction. After the transaction is verified, please check your email for the download. To view all available procedures click here.

CE Marking Procedure (SYS-025) Read More »

Clinical Procedure – Investigations, not Evaluations

This clinical procedure explains the basics of clinical investigations, but if you are looking for a CER procedure you want SYS-041 instead.

Your cart is empty

Clinical Procedure (SYS-009)

Clinical Procedure Clinical Procedure   Investigations, not Evaluations
SYS-009 - Clinical Procedure
SYS-009 Clinical Procedure
Price: $299.00

When is the Webinar about this Clinical Procedure?

This webinar will be live webinar on Monday, July 1, 2024 @ 10:30 am ET. The session will also be recorded. You can purchase it on-demand and watch the training as often as you wish.

What you will receive:

The purpose of this (15)-page procedure is to define the process for managing clinical studies and post-market clinical follow-up (PMCF) studies. This procedure provides an overview of managing clinical studies for medical devices. This is the primary document meeting the applicable regulatory requirements for Clinical Studies and PMCF Studies as defined in your company’s Quality System Manual (POL-001). The following is a list of documents included:

  • SYS-009 A D5 Clinical Procedure
  • TMP-037 A D1 Generic Clinical Study Template
  • TMP-038 A D1 Informed Consent Template
  • TMP-xxx Clinical Synopsis Template

This procedure is meant to be a high-level procedure for companies that are outsourcing clinical investigations to a Clinical Research Organization (CRO). If your company intends to hire a Clinical Research Coordinator (CRC) and Clinical Research Associate (CRA), then you will need to create work instructions for site selection, site training, site monitoring, patient recruitment, etc.

Please note: This product will be delivered to the email address provided in the shopping cart transaction. After the transaction is verified, please check your email for the download. 


Clinical Procedure Clinical Procedure   Investigations, not Evaluations
To view all available procedures click here

If you would like to learn more about clinical studies, please watch our webinar on clinical study basics with Jan Dugas.

To review a sample Medical Device Academy procedure click below:

managment review sample SOP Clinical Procedure   Investigations, not Evaluations

About Your Instructor

Winter in VT 2024 150x150 Clinical Procedure   Investigations, not Evaluations

Rob Packard is a regulatory consultant with ~25 years of experience in the medical device, pharmaceutical, and biotechnology industries. He is a graduate of UConn in Chemical Engineering. Rob was a senior manager at several medical device companies—including the President/CEO of a laparoscopic imaging company. His Quality Management System expertise covers all aspects of developing, training, implementing, and maintaining ISO 13485 and ISO 14971 certifications. From 2009 to 2012, he was a lead auditor and instructor for one of the largest Notified Bodies. Rob’s specialty is regulatory submissions for high-risk medical devices, such as implants and drug/device combination products for CE marking applications, Canadian medical device applications, and 510(k) submissions. The most favorite part of his job is training others. He can be reached via phone at +1.802.281.4381 or by email. You can also follow him on YouTube, LinkedInor Twitter.

Clinical Procedure – Investigations, not Evaluations Read More »

Record Control Procedure Bundle

This record control procedure webinar bundle reviews the requirements of record control in ISO 13485:2016, Clause 4.2.5 and 21 CFR 820.180.

Your cart is empty

damage to quality records Record Control Procedure Bundle
Do you have a record control procedure?

I’m sure your record control area doesn’t look as bad as the photo above, but do you have a record control procedure? The original webinar on this topic was called “Good Documentation Practices 101.” Based on feedback from customers, the webinar content has been completely rewritten and has more detail for people that are new to medical device quality management systems. The latest webinar also references the sections of the Record Control Procedure (SYS-002) to emphasize the importance of specific procedure requirements.

What will you receive when you purchase this bundle?

Anyone that purchases the record control procedure webinar bundle will automatically receive both the updated version of the Record Control Procedure (SYS-002), any future updates to the procedure, the associated forms, and access to the new webinar.

Typically webinars are sold on our website for $129, and procedures are sold for $299. This bundle is sold for $299. As always, you receive a copy of the native slide deck and a link for downloading the recording.

ISO 13485:2016 Requirements for Record Control Procedure (SYS-002)

On March 1, 2016, the 2016 version of ISO 13485 was released. The new version of the Standard has no new requirements for control of records that were not included in the 2003 version of the Standard, but there are general requirements for all quality system procedures that have been updated in the procedure.

When is the webinar for the Record Control Procedure?

The webinar will be conducted live on Friday, January 13, 2017, @ Noon EST.

Q&A

During the original live webinar, you can submit questions via email or the chatbox. If you have company-specific questions, or you are purchasing the recording after January 13, 2017, please send me a request to set-up a private call to discuss your specific issues.

Record Control Procedure Webinar Bundle available for $299.00:

download 150x150 Record Control Procedure Bundle
SYS-002 Record Control Procedure and Webinar Bundle
SYS-002 Record Control Procedure and Webinar Bundle
Price: $299.00

To view, all available procedures click here

To review a sample Medical Device Academy procedure, click below:

managment review sample SOP Record Control Procedure Bundle

About Your Instructor

Rob 150x150 Record Control Procedure Bundle

Rob Packard is a regulatory consultant with ~25 years of experience in the medical device, pharmaceutical, and biotechnology industries. He is a graduate of UConn in Chemical Engineering. Rob was a senior manager at several medical device companies—including the President/CEO of a laparoscopic imaging company. His Quality Management System expertise covers all aspects of developing, training, implementing, and maintaining ISO 13485 and ISO 14971 certification. From 2009-2012, he was a lead auditor and instructor for one of the largest Notified Bodies. Rob’s specialty is regulatory submissions for high-risk medical devices, such as implants and drug/device combination products for CE marking applications, Canadian medical device applications, and 510(k) submissions. The most favorite part of his job is training others. He can be reached via phone at 802.281.4381 or email. You can also follow him on Google+, LinkedIn, or Twitter.

Record Control Procedure Bundle Read More »

Post-Market Surveillance Procedure (SYS-019)

SYS-019 is our post-market surveillance procedure that meets the requirements for ISO 13485, the EU MDR, and SOR 98/282.

Your cart is empty

 

When is the live webinar scheduled for this procedure bundle?

The live webinar was scheduled for Monday, October 21, 2024 @ 10:30 a.m. ET. If you purchased the procedure before October 21, you received login information to participate in the live webinar. The webinar was be hosted on Streamyard.com. If you were unable to participate in the live webinar, please send us your questions. You will be able to download the recording from the Dropbox folder after the live webinar and you can watch it as many times as needed.

 

Contents Sold with the Post-Market Surveillance Procedure

We have updated our Post-Market Surveillance Procedure (SYS-019) to include new Canadian and EU requirements, including templates for the following:

sys 019 items Post Market Surveillance Procedure (SYS 019)

New Canadian Post-Market Surveillance Requirements

Post-Market Surveillance is the process in ISO 13485:2016 quality systems receiving the most amount of focus by MDSAP auditors due to updates in the Canadian Medical Devices Regulations (SOR/2020-262) and related guidance documents:

The new regulations require creating and maintaining post-market surveillance summary reports for Class II, III, and IV devices licensed for distribution in Canada.

New EU Post-Market Surveillance Requirements

Post-Market Surveillance is the process in ISO 13485:2016 quality systems receiving the most amount of focus by Notified Body auditors due to updates in the European Medical Device Regulations:

The new regulations require an additional post-market surveillance section of your technical as defined in Annex III of the new MDR. The are also new requirements for the creation of a Periodic Safety Update Report (PSUR) for Class IIa, Class IIb, and Class III devices. It is also an expectation for companies to conduct post-market clinical follow-up studies for most devices.

We also updated our post-market surveillance (PMS) plan template (TMP-031). The new template is now integrated with risk management requirements to include the risk management requirements in ISO 14971:2019, Clause 10 for collecting production and post-production information.

Additional Resources

If you are looking for additional guidance on post-market surveillance for medical devices, there is a new guidance available for post-market surveillance: ISO/TR 20416:2020 – Medical Devices – Post-Market Surveillance for Manufacturers. Medical Device Academy also created two webinars that you might be interested in for training purposes:

 
Post Market Surveillance Post Market Surveillance Procedure (SYS 019)
SYS-019 Post-Market Surveillance Procedure/Form
SYS-019 Post-Market Surveillance Procedure/Form
Price: $299.00
 

Please note: This product will be delivered to the email address provided in the shopping cart transaction. After the transaction is verified, please check your email for the download. 
Post Market Surveillance Post Market Surveillance Procedure (SYS 019)

 To view all available procedures click here

To review a sample Medical Device Academy procedure click below:

managment review sample SOP Post Market Surveillance Procedure (SYS 019)

 

Screenshot from webinar 150x150 Post Market Surveillance Procedure (SYS 019)

Rob Packard is a regulatory consultant with ~25 years of experience in the medical device, pharmaceutical, and biotechnology industries. He is a graduate of UConn in Chemical Engineering. Rob was a senior manager at several medical device companies—including the President/CEO of a laparoscopic imaging company. His Quality Management System expertise covers all aspects of developing, training, implementing, and maintaining ISO 13485 and ISO 14971 certifications. From 2009 to 2012, he was a lead auditor and instructor for one of the largest Notified Bodies. Rob’s specialty is regulatory submissions for high-risk medical devices, such as implants and drug/device combination products for CE marking applications, Canadian medical device applications, and 510k submissions. The most favorite part of his job is training others. He can be reached via phone at +1.802.258.1881 or by email. You can also follow him on YouTubeLinkedIn, or Instagram.

Post-Market Surveillance Procedure (SYS-019) Read More »

Change Control Procedure (SYS-006) and Webinar

A change control procedure ensures changes to the design, manufacture, or labeling of products are controlled in accordance with regulations.

Your cart is empty

The purpose of this procedure is to ensure that device modifications, manufacturing process changes, and supplier changes within the scope of your company’s quality management system are planned, approved, and implemented in a controlled manner, maintaining the safety and efficacy of the product and the effectiveness of the quality management system.

When is the Change Control Procedure Webinar?

The change control procedure webinar will be hosted on August 5, 2024 @ 10:30 a.m. ET. The webinar will be live, and you will receive login instructions if you purchased the change control procedure prior to the scheduled live webinar. The webinar will also be recorded. You will be able to download the webinar from our Dropbox folder and watch the webinar as many times as needed–including the training of future employees.

What is included with the Change Control Procedure?

The purchase of the Change Control Procedure includes forms, logs, a template, and a training webinar. These documents are updated for ISO 13485:2016, the Canadian Medical Devices Regulation, and the new European Regulations. The following items are included:

  • SYS-006 A, Change Control Procedure
  • FRM-012 A, Change Note
  • LST-009  A, Change Register
  • TMP-029 A, Letter-to-File Template (LTF) for 510(k) Cleared Devices
  • Native Slide Deck
  • Login Information for the Live Webinar (if purchased on or before August 5, 2024)
  • Recording of the Webinar (after August 5, 2024)

Scope of the Procedure

This procedure applies to any medical device that has been released for manufacture and to any changes to the manufacturing processes or supplier that will result in a change to product or process documentation or that otherwise may potentially impact product characteristics or safety. This procedure meets the requirements of ISO 13485:2016/Amd 2021, SOR 98/282, and Regulation (EU) 2017/745.

change control Change Control Procedure (SYS 006) and Webinar
SYS-006 Change Control Procedure
This procedure explains the design change control process, including the decision regarding whether a new 510(k) submission is required for modifications to 510(k) cleared device. A webinar explaining how to revise, edit, and implement the procedure is included.
Price: $299.00

Please note: This product will be delivered to the email address provided in the shopping cart transaction. After the transaction is verified, please check your email for the download.

The video above announces a Design Change Control Webinar related to this Change Control Procedure. The webinar was hosted live on January 20, 2022, and a webinar recording is available on-demand if you follow the above link. The presentation had 37 slides, and the recording duration was 57 minutes. This video is also included in our Turnkey Quality System.

change control Change Control Procedure (SYS 006) and Webinar

 To view all available procedures click here

To review a sample Medical Device Academy procedure click below:

managment review sample SOP Change Control Procedure (SYS 006) and Webinar

About Your Instructor

Winter in VT 2024 150x150 Change Control Procedure (SYS 006) and Webinar

Rob Packard is a regulatory consultant with ~25 years of experience in the medical device, pharmaceutical, and biotechnology industries. He is a graduate of UConn in Chemical Engineering. Rob was a senior manager at several medical device companies—including the President/CEO of a laparoscopic imaging company. His Quality Management System expertise covers all aspects of developing, training, implementing, and maintaining ISO 13485 and ISO 14971 certifications. From 2009 to 2012, he was a lead auditor and instructor for one of the largest Notified Bodies. Rob’s specialty is regulatory submissions for high-risk medical devices, such as implants and drug/device combination products for CE marking applications, Canadian medical device applications, and 510k submissions. The most favorite part of his job is training others. He can be reached via phone at +1.802.281.4381 or by email. You can also follow him on YouTubeLinkedIn, or Twitter.

Change Control Procedure (SYS-006) and Webinar Read More »

Complaint Investigation Case Study (21 CFR 820.198): Part 2

This article is part 2 of a two-part series specific to complaint investigation requirements as specified in 21 CFR 820.198 (http://bit.ly/21CFR820198) of FDA QSR. This second part explains how to perform a complaint investigation and provides a complaint investigation case study.

complaint part 2 Complaint Investigation Case Study (21 CFR 820.198): Part 2

 

Last week’s blog  reviewed the requirements for a complaint investigation, while this blog includes the following information on how to conduct an investigation:h

  1. How thorough should your investigation be?
  2. Investigation Methods
  3. Verification of the Cause
  4. Documenting Your Investigation
  5. Complaint Investigation Case Study

How thorough should your investigation be?

The depth of investigation should be appropriate to the importance of the complaint. If a previous complaint of similar nature has already been investigated, the investigation may only gather enough information to verify that complaint has the same root cause. However, if a complaint involves an adverse event (i.e., is reportable under 21 CFR 803), then additional information needs to be recorded in the complaint record as per 21 CFR 820.198d:

  1. Does the device fail to meet specifications?
  2. Was the device used for treatment or diagnosis?
  3. What was the relationship, if any, between the device and the reported event?

If the person gathering information from the complainant cannot immediately identify a cause code, or the incident involves a severe injury or death, then it is essential to collect as much information as possible. Typically, the complainant will be asked to return the device to determine if the device malfunctioned.

Investigation Methods

A complaint investigation is not any different from any investigation you perform for a CAPA. The most critical first step is to determine the cause of the complaint. To determine the cause, you need to sample additional records and inspect the device if it is available. If the device is not available, you might also look at other product from the same lot that remains in inventory. The following article I wrote suggests seven ways to investigate a complaint when a device is not returned: http://bit.ly/DeviceNotReturned.

One of the methods described in the article above is an Ishikawa Diagram or “Fishbone Diagram.” This is one of the five root cause analysis tools that I teach in my CAPA webinar (http://bit.ly/enKapCAPAwebinar). Ishikawa Diagrams are an ideal tool for root cause analysis if you have no idea what the cause of the complaint is because this tool provides a systematic process for narrowing down the potential causes, to the narrow few that are most likely. You are not required to use this tool, but you should describe in your complaint record what type of root cause analysis was performed.

Verification of Cause

Once you have identified the root cause, or at least narrowed your list to the most likely causes, you should then verify that the cause will result in the observed malfunction by recreating the scenario if possible. Ideally, you should be able to simulate the event that resulted in the complaint and demonstrate that you can reproduce the problem. This is important because if you cannot verify the cause of a device malfunction, then you will have difficulty verifying the effectiveness of corrective actions for an infrequent complaint.

Documenting Your Investigation

There is no specific format for the way a complaint investigation is documented. Still, most complaint records have a small section on the complaint form that allows them to write a short paragraph summarizing the investigation and the results. Unfortunately, most of the spaces provided on forms are completely inadequate for the amount of information that should be recorded. Therefore, the best approach is often to write, “See attached complaint investigation.” This is especially true if the complaint is reportable (i.e., requires MDR under 21 CFR 803). Good documentation is quantitative and specific. You need to identify which records were sampled as part of the investigation. You should demonstrate that you have expanded your initial search to determine if the problem exists in multiple production lots of the same product code, multiple product codes within the same product family and any other product families that may use similar raw materials, design features, equipment, testing methods or procedures.

Complaint Investigation Case Study

If your company manufactures cast orthopedic implants for the knee and you receive a complaint about an implant that has a small imperfection in the bearing surface of the femoral implant, you may need to perform an investigation–especially if this has not occurred previously. You should request a return of the implant for inspection to verify that the imperfection is nonconforming and not just a cosmetic defect.

Your investigation should include a review of the lot history record for an entire lot of implants–as well as any other parts that they may have been cast at the same time. All the process conditions identified throughout the manufacturing process should be compared to the validated process parameters. Special attention should be given to the inspection results that were recorded for the castings (i.e., radiographic inspection, fluorescent penetrant inspection, and metallurgical inspection). Ideally, these inspection methods should be repeated for 100% of the production lot to ensure that the inspection results meet the acceptance criteria. Documentation of the investigation should include copies of all records that were reviewed and photos if visual inspections were repeated.

If you are interested in learning more about complaint handling, you might be interested in downloading the webinar that Medical Device Academy recorded last year for complaint handling and vigilance reporting (http://bit.ly/Complaint-Webinar-Landing). We can also help you one-on-one with a current complaint investigation you are conducting. Please don’t hesitate to contact me. Mobile: 802.281.4381 or rob@13485cert.com.

Complaint Investigation Case Study (21 CFR 820.198): Part 2 Read More »

Design Controls Procedure

This procedure bundle is our updated design control procedure for compliance with 21 CFR 820.30 and ISO 13485:2016, Clause 7.3.1.

Your cart is empty

Design Controls Procedure

The purpose of this design controls procedure is to ensure that the product is developed in a systematic way, ensuring that risk control measures are incorporated in the design, that all design outputs are verified against specifications and validated against user requirements, and that regulatory and standards requirements are fulfilled. The procedure is also bundled with a webinar that explains how to review, edit, and implement the procedure for your company. In the webinar we will explain what order to use the templates and forms in a design project. We are also making some edits to the procedure, forms, and templates in preparation for the live webinar.

When is the live webinar scheduled for this procedure bundle?

The live webinar is scheduled for Monday, September 16, 2024 @ 10:30 a.m. ET. If you purchased the procedure before September 16, you will receive login information to participate in the live webinar. The webinar will be hosted in Streamyard.com. If you are unable to participate in the live webinar, please send us your questions in advance so that we can be sure to address your questions in the live webinar. You will be able to download the recording from the Dropbox folder after the live webinar and you can watch it as many times as needed. If you need training on how to manage you design control process, that is covered in a different training webinar.

What is included in the design control procedure?

The design controls procedure scope covers the design and development of new medical devices, including their packaging and labeling, and to modifications and upgrades of existing devices. This procedure applies from the approval of the initial design. This procedure is not applicable to research activities that precede design and development.

design control SOP Design Controls Procedure
SYS-008 - Design Control Procedure
This procedure package includes the following documents: 1) SYS-008, 2) FRM-018, 3) FRM-019, 4) TMP-021, 5) FRM-011, 6) TMP-022, 7) TMP-023, 8) TMP-024, 9) TMP-025, 10) TMP-026, and 11) TMP-027. You will also receive access to a webinar that explains how to review, edit, and implement the procedure in your quality system.
Price: $299.00

Please note: This product will be delivered to the email address provided in the shopping cart transaction. After the purchase is verified, please check your email for the download. 

The purchase of this procedure also includes several forms and templates. The design review form is very simple to streamline your meeting documentation and simplify the process. The design requirements matrix is a fusion of two different documents used by other device companies: 1) a design FMEA, and 2) an input/output/verification/validation (IOVV) matrix. The design plan is a combined design and risk management plan. The plan combines all the requirements of: 1) a phase/gate design process; 2) the risk management activities required in ISO 14971:2019, and Annex I, sections 1-9, of Regulation (EU) 2017/745; 3) software validation documentation requirements; and 4) formative and summative usability testing requirements. The following is the full list of forms and templates provided with the SYS-008, Design Controls Procedure:

SYS 008 Design Controls Procedure

If you are interested in our design controls procedure, you might also be interested in our risk management procedure (SYS-010) and our two related training webinars:

  1. Design Controls Training Webinar
  2. ISO 14971 Risk Management Webinar- updated for ISO/DIS 14971:2018 & Regulation (EU) 2017/745 

design control SOP Design Controls Procedure

To view all available procedures, click here.

To review a sample Medical Device Academy procedure, click below:

managment review sample SOP Design Controls Procedure

About Your Instructor

Winter in VT 2024 150x150 Design Controls Procedure

Rob Packard is a regulatory consultant with ~25 years of experience in the medical device, pharmaceutical, and biotechnology industries. He is a graduate of UConn in Chemical Engineering. Rob was a senior manager at several medical device companies—including the President/CEO of a laparoscopic imaging company. His Quality Management System expertise covers all aspects of developing, training, implementing, and maintaining ISO 13485 and ISO 14971 certifications. From 2009 to 2012, he was a lead auditor and instructor for one of the largest Notified Bodies. Rob’s specialty is regulatory submissions for high-risk medical devices, such as implants and drug/device combination products for CE marking applications, Canadian medical device applications, and 510k submissions. The most favorite part of his job is training others. He can be reached via phone at +1.802.281.4381 or by email. You can also follow him on YouTubeLinkedIn, or Instagram.

Design Controls Procedure Read More »

Scroll to Top